Intercept ICPT reported positive top-line results from its phase 3 results of obeticholic acid (OCA) in patients with liver fibrosis due to nonalcoholic steatohepatitis (NASH) on Feb. 19. The trial ...
Wall Street expects a year-over-year increase in earnings on lower revenues when Intercept Pharmaceuticals (ICPT) reports results for the quarter ended December 2022. While this widely-known consensus ...
Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients Trial met the primary efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback